Enhancer-associated RNAs as therapeutic targets

Bibliography

• De Santa F, Barozzi I, Mietton F, et al. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol 2010;8(5):e1000384
   PubMed Web of Science ®Google Scholar
• Kim TK, Hemberg M, Gray JM, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010;465(7295):182-7
   PubMed Web of Science ®Google Scholar
• Lam MT, Cho H, Lesch HP, et al. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 2013;498(7455):511-15
   PubMed Web of Science ®Google Scholar
• Li W, Notani D, Ma Q, et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 2013;498(7455):516-20
   PubMed Web of Science ®Google Scholar
• Melo CA, Drost J, Wijchers PJ, et al. eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell 2013;49(3):524-35
   PubMed Web of Science ®Google Scholar
• Banerji J, Rusconi S, Schaffner W. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell 1981;27(2 Pt 1):299-308
   PubMed Web of Science ®Google Scholar
• Struhl K, Kadosh D, Keaveney M, et al. Activation and repression mechanisms in yeast. Cold Spring Harb Symp Quant Biol 1998;63:413-21
   PubMedGoogle Scholar
• Ghavi-Helm Y, Klein FA, Pakozdi T, et al. Enhancer loops appear stable during development and are associated with paused polymerase. Nature 2014;512(7512):96-100
   PubMed Web of Science ®Google Scholar
• Shi J, Whyte WA, Zepeda-Mendoza CJ, et al. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev 2013;27(24):2648-62
   PubMed Web of Science ®Google Scholar
• Maurano MT, Humbert R, Rynes E, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012;337(6099):1190-5
   PubMed Web of Science ®Google Scholar
• Thurman RE, Rynes E, Humbert R, et al. The accessible chromatin landscape of the human genome. Nature 2012;489(7414):75-82
   PubMed Web of Science ®Google Scholar
• ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489(7414):57-74
   PubMed Web of Science ®Google Scholar
• Heinz S, Benner C, Spann N, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 2010;38(4):576-89
   PubMed Web of Science ®Google Scholar
• Ghisletti S, Barozzi I, Mietton F, et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 2010;32(3):317-28
   PubMed Web of Science ®Google Scholar
• Serandour AA, Avner S, Percevault F, et al. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res 2011;21(4):555-65
   PubMed Web of Science ®Google Scholar
• Zaret KS, Carroll JS. Pioneer transcription factors: establishing competence for gene expression. Genes Dev 2011;25(21):2227-41
   PubMed Web of Science ®Google Scholar
• Lee CS, Friedman JR, Fulmer JT, et al. The initiation of liver development is dependent on Foxa transcription factors. Nature 2005;435(7044):944-7
   PubMed Web of Science ®Google Scholar
• Lam EW, Brosens JJ, Gomes AR, et al. Forkhead box proteins: tuning forks for transcriptional harmony. Nat Rev Cancer 2013;13(7):482-95
   PubMed Web of Science ®Google Scholar
• Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007;129(4):823-37
   PubMed Web of Science ®Google Scholar
• Hu G, Cui K, Northrup D, et al. H2A.Z facilitates access of active and repressive complexes to chromatin in embryonic stem cell self-renewal and differentiation. Cell Stem Cell 2013;12(2):180-92
   PubMed Web of Science ®Google Scholar
• Jin C, Zang C, Wei G, et al. H3.3/H2A.Z double variant-containing nucleosomes mark ‘nucleosome-free regions’ of active promoters and other regulatory regions. Nat Genet 2009;41(8):941-5
   PubMed Web of Science ®Google Scholar
• Gross DS, Garrard WT. Nuclease hypersensitive sites in chromatin. Annu Rev Biochem 1988;57:159-97
   PubMed Web of Science ®Google Scholar
• He HH, Meyer CA, Shin H, et al. Nucleosome dynamics define transcriptional enhancers. Nat Genet 2010;42(4):343-7
   PubMed Web of Science ®Google Scholar
• Heintzman ND, Hon GC, Hawkins RD, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009;459(7243):108-12
   PubMed Web of Science ®Google Scholar
• Creyghton MP, Cheng AW, Welstead GG, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA 2010;107(50):21931-6
   PubMed Web of Science ®Google Scholar
• Rada-Iglesias A, Bajpai R, Swigut T, et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011;470(7333):279-83
   PubMed Web of Science ®Google Scholar
• Pekowska A, Benoukraf T, Zacarias-Cabeza J, et al. H3K4 tri-methylation provides an epigenetic signature of active enhancers. Embo J 2011;30(20):4198-210
   PubMed Web of Science ®Google Scholar
• Ernst J, Kheradpour P, Mikkelsen TS, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011;473(7345):43-9
   PubMed Web of Science ®Google Scholar
• Bogdanovic O, Fernandez-Minan A, Tena JJ, et al. Dynamics of enhancer chromatin signatures mark the transition from pluripotency to cell specification during embryogenesis. Genome Res 2012;22(10):2043-53
   PubMed Web of Science ®Google Scholar
• Bonn S, Zinzen RP, Girardot C, et al. Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat Genet 2012;44(2):148-56
   PubMed Web of Science ®Google Scholar
• Loven J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013;153(2):320-34
   PubMed Web of Science ®Google Scholar
• Whyte WA, Orlando DA, Hnisz D, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013;153(2):307-19
   PubMed Web of Science ®Google Scholar
• Pott S, Lieb JD. What are super-enhancers? Nat Genet 2015;47(1):8-12
   PubMed Web of Science ®Google Scholar
• Koch F, Fenouil R, Gut M, et al. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat Struct Mol Biol 2011;18(8):956-63
   PubMed Web of Science ®Google Scholar
• Core LJ, Martins AL, Danko CG, et al. Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers. Nat Genet 2014;46(12):1311-20
   PubMed Web of Science ®Google Scholar
• Andersson R, Gebhard C, Miguel-Escalada I, et al. An atlas of active enhancers across human cell types and tissues. Nature 2014;507(7493):455-61
   PubMed Web of Science ®Google Scholar
• Orom UA, Derrien T, Beringer M, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010;143(1):46-58
   PubMed Web of Science ®Google Scholar
• Hsieh CL, Fei T, Chen Y, et al. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation. Proc Natl Acad Sci USA 2014;111(20):7319-24
   PubMed Web of Science ®Google Scholar
• Lai F, Orom UA, Cesaroni M, et al. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 2013;494(7438):497-501
   PubMed Web of Science ®Google Scholar
• Wang D, Garcia-Bassets I, Benner C, et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 2011;474(7351):390-4
   PubMed Web of Science ®Google Scholar
• Hah N, Murakami S, Nagari A, et al. Enhancer transcripts mark active estrogen receptor binding sites. Genome Res 2013;23(8):1210-23
   PubMed Web of Science ®Google Scholar
• Schaukowitch K, Joo JY, Liu X, et al. Enhancer RNA facilitates NELF release from immediate early genes. Mol Cell 2014;56(1):29-42
   PubMed Web of Science ®Google Scholar
• Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005;6(2):95-108
   PubMed Web of Science ®Google Scholar
• Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461(7265):747-53
   PubMed Web of Science ®Google Scholar
• Consortium EP, Bernstein BE, Birney E, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489(7414):57-74
   PubMed Web of Science ®Google Scholar
• Heinz S, Romanoski CE, Benner C, et al. Effect of natural genetic variation on enhancer selection and function. Nature 2013;503(7477):487-92
   PubMed Web of Science ®Google Scholar
• Meng FL, Du Z, Federation A, et al. Convergent transcription at intragenic super-enhancers targets aid-initiated genomic instability. Cell 2014;159(7):1538-48
   PubMed Web of Science ®Google Scholar
• Qian J, Wang Q, Dose M, et al. B Cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell 2014;159(7):1524-37
   PubMed Web of Science ®Google Scholar
• Di Noia JM, Neuberger MS. Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem 2007;76:1-22
   PubMed Web of Science ®Google Scholar
• Hakim O, Resch W, Yamane A, et al. DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes. Nature 2012;484(7392):69-74
   PubMed Web of Science ®Google Scholar
• Hnisz D, Abraham BJ, Lee TI, et al. Super-enhancers in the control of cell identity and disease. Cell 2013;155(4):934-47
   PubMed Web of Science ®Google Scholar
• Mousavi K, Zare H, Dell’orso S, et al. eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Mol Cell 2013;51(5):606-17
   PubMed Web of Science ®Google Scholar
• Step SE, Lim HW, Marinis JM, et al. Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARgamma-driven enhancers. Genes Dev 2014;28(9):1018-28
   PubMed Web of Science ®Google Scholar
• NE II, Heward JA, Roux B, et al. Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes. Nat Commun 2014;5:3979
   PubMed Web of Science ®Google Scholar
• Léveillé N, Melo CA, Rooijers K, et al. Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA. Nat Commun 2015
   PubMed Web of Science ®Google Scholar
• Kole R, Krainer AR, Altman S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 2012;11(2):125-40
   PubMed Web of Science ®Google Scholar
• Koshkin AA, Wengel J. Synthesis of Novel 2’,3’-Linked Bicyclic Thymine Ribonucleosides. J Org Chem 1998;63(8):2778-81
   PubMed Web of Science ®Google Scholar
• Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013;368(18):1685-94
   PubMed Web of Science ®Google Scholar
• Lieberman J, Sarnow P. Micromanaging hepatitis C virus. N Engl J Med 2013;368(18):1741-3
   PubMed Web of Science ®Google Scholar
• Jopling CL, Yi M, Lancaster AM, et al. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005;309(5740):1577-81
   PubMed Web of Science ®Google Scholar
• Stirchak EP, Summerton JE, Weller DD. Uncharged stereoregular nucleic acid analogs: 2. Morpholino nucleoside oligomers with carbamate internucleoside linkages. Nucleic Acids Res 1989;17(15):6129-41
   PubMed Web of Science ®Google Scholar
• Hudziak RM, Summerton J, Weller DD, et al. Antiproliferative effects of steric blocking phosphorodiamidate morpholino antisense agents directed against c-myc. Antisense Nucleic Acid Drug Dev 2000;10(3):163-76
   PubMedGoogle Scholar
• Filippakopoulos P, Picaud S, Mangos M, et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 2012;149(1):214-31
   PubMed Web of Science ®Google Scholar
• Anand P, Brown JD, Lin CY, et al. BET bromodomains mediate transcriptional pause release in heart failure. Cell 2013;154(3):569-82
   PubMed Web of Science ®Google Scholar
• Adelman K, Lis JT. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet 2012;13(10):720-31
   PubMed Web of Science ®Google Scholar
• Peterlin BM, Price DH. Controlling the elongation phase of transcription with P-TEFb. Mol Cell 2006;23(3):297-305
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature 2010;468(7327):1067-73
   PubMed Web of Science ®Google Scholar
• Nicodeme E, Jeffrey KL, Schaefer U, et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010;468(7327):1119-23
   PubMed Web of Science ®Google Scholar
• Delmore JE, Issa GC, Lemieux ME, et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011;146(6):904-17
   PubMed Web of Science ®Google Scholar
• Kanno T, Kanno Y, LeRoy G, et al. BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones. Nat Struct Mol Biol 2014;21(12):1047-57
   PubMed Web of Science ®Google Scholar
• Jackson AL, Linsley PS. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 2010;9(1):57-67
   PubMed Web of Science ®Google Scholar
• Reyon D, Tsai SQ, Khayter C, et al. FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol 2012;30(5):460-5
   PubMed Web of Science ®Google Scholar
• Bedell VM, Wang Y, Campbell JM, et al. In vivo genome editing using a high-efficiency TALEN system. Nature 2012;491(7422):114-18
   PubMed Web of Science ®Google Scholar
• Manjunath N, Dykxhoorn DM. Advances in synthetic siRNA delivery. Discov Med 2010;9(48):418-30
   PubMed Web of Science ®Google Scholar
• Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013;339(6121):819-23
   PubMed Web of Science ®Google Scholar
• Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012;337(6096):816-21
   PubMed Web of Science ®Google Scholar
• Mali P, Yang L, Esvelt KM, et al. RNA-guided human genome engineering via Cas9. Science 2013;339(6121):823-6
   PubMed Web of Science ®Google Scholar
• Jiang W, Bikard D, Cox D, et al. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 2013;31(3):233-9
   PubMed Web of Science ®Google Scholar
• Cho SW, Kim S, Kim JM, et al. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 2013;31(3):230-2
   PubMed Web of Science ®Google Scholar
• Aran D, Hellman A. DNA methylation of transcriptional enhancers and cancer predisposition. Cell 2013;154(1):11-13
   PubMed Web of Science ®Google Scholar